Status:
UNKNOWN
Immune Response to Vaccination Against Covid-19, a Follow up Study
Lead Sponsor:
Umeå University
Collaborating Sponsors:
Region Västerbotten
Värmland County Council, Sweden
Conditions:
Vaccination; Infection
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The study investigates the immune response after vaccination in individuals with and without pre-existing immunity to Coronavirus disease (COVID) -19. The participants are followed and sampled up to 4...
Detailed Description
The main objective is to investigate if the antibody development to SARS-CoV-2 S protein differ after vaccination in those who have had a previous SARS-CoV-2 infection compared to Covid-19 naive indiv...
Eligibility Criteria
Inclusion
- Consents to participate in the study
- Age ≥ 18 years
Exclusion
- Age \<18 years
- Incapable of giving informed consent
- Contraindication to vaccination
- Severe disease
- Ongoing treatment that is judged to affect the vaccine response (Does not include Rituximab which is allowed after individual consideration). Steroids \> 15 mg orally per day.
Key Trial Info
Start Date :
March 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04920357
Start Date
March 31 2021
End Date
December 31 2024
Last Update
June 9 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Mälarsjukhuset
Eskilstuna, Sweden, 633 49
2
Karlstad Central hospital
Karlstad, Sweden, 651 85
3
Örebro University hospital
Örebro, Sweden, 701 85
4
Östersund hospital
Östersund, Sweden, 831 83